Skip to main content

and
  1. Article

    Open Access

    Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma

    To analyse the prognostic significance of preoperative C-reactive protein (CRP) serum level in patients with upper urinary tract urothelial carcinoma (UUT-UC).

    Barbara Stein, Andres Jan Schrader, Gerd Wegener, Christoph Seidel in BMC Cancer (2013)

  2. Article

    Open Access

    Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients

    To evaluate the prognostic significance of the pre-operative C-reactive protein (CRP) serum level in patients with renal cell cancer (RCC).

    Sandra Steffens, Astrid Köhler, Raphael Rudolph, Hendrik Eggers in BMC Cancer (2012)

  3. Article

    Open Access

    Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

    The use of imatinib mesylate is associated with a progression free survival of 41 months in first line treatment of metastatic or locally advanced gastrointestinal stromal tumors (GIST) and other studies appro...

    Christoph Seidel, Martin Fenner, Florian Länger, Heike Bantel, Arnold Ganser in BMC Cancer (2012)

  4. Article

    Open Access

    Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma

    Data on sequential therapy in patients with metastatic renal cell carcinoma (mRCC) and intrinsic resistance to receptor tyrosine kinase inhibitor (rTKI) treatment remains vague.

    Jonas Busch, Christoph Seidel, Steffen Weikert, Ingmar Wolff in BMC Cancer (2011)